drugset / Trial / NCT00165477
Study of Lenalidomide and XRT in Patients With Newly Diagnosed Glioblastoma Multiforme
Phase 2
Completed
23 enrolled
Dana-Farber Cancer Institute
Beth Israel Deaconess Medical Center · collabBrigham and Women's Hospital · collabCelgene Corporation · collabMassachusetts General Hospital · collabUniversity of Virginia · collab
Non-randomizedSingle-groupOpen-labelTreatment
Summary
\- The purpose of this study is to find out if the combination of lenalidomide and radiation therapy is effective in controlling tumor growth in patients with newly-diagnosed supratentorial glioblastoma or gliosarcoma.
Timeline
- Start
- 2005-09
- Primary completion
- 2007-11
- Completion
- 2009-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lenalidomide | Other / unclassified | — | Oral |